US2016041551A1PendingUtilityA1
Methods for monitoring integrated continuous pharmacetical manufacturing processes
Individually held — no corporate assignee on recordPriority: May 6, 2004Filed: Oct 16, 2015Published: Feb 11, 2016
Est. expiryMay 6, 2024(expired)· nominal 20-yr term from priority
Inventors:Shane M. Popp
G05B 23/0235G05B 23/0224G05B 2223/02G05B 2219/1112G06Q 10/06G05B 2219/11
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for monitoring integrated continuous pharmaceutical manufacturing processes are described and disclosed herein. The method continuously monitors and creates a historic record of the pharmaceutical manufacturing process and provides it to an end user or a plurality of end users. Consequently, the methods provide a means to perform quality control on an integrated level whereby a pharmaceutical manufacturer can ensure data and product integrity and minimize cost.
Claims
exact text as granted — not AI-modified1 ) A method comprising,
a) continuously monitoring an acceptance criteria in a pharmaceutical manufacturing process, where said pharmaceutical manufacturing process produces an active ingredient and wherein the monitoring occurs at a critical control point; b) compiling data obtained during the monitoring of the pharmaceutical manufacturing process and storing the data in a historic record, wherein the historic record comprises a lot number, control number, or batch number; c) analyzing the historic record to provide a comparative analysis against the acceptance criteria, wherein the analysis is performed at various times throughout the pharmaceutical manufacturing production cycle; d) taking corrective action during the pharmaceutical manufacturing process based on a comparative analysis against the acceptance criteria, wherein said corrective action comprises modifying the pharmaceutical manufacturing process.
2 ) The method of claim 1 , wherein the pharmaceutical manufacturing process is a batch pharmaceutical manufacturing process.
3 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes a chromatography/separation system.
4 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes a mixing tank.
5 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes a clean-in-place system.
6 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes a time-stamped audit trail.
7 ) The method of claim 1 , wherein the acceptance criteria is predetermined by a quality control unit.
8 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes filling equipment.
9 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes a lyophilizer/freeze.
10 ) The method of claim 1 , wherein the pharmaceutical manufacturing process utilizes a modular cleanroom.
11 ) A method comprising,
a) continuously monitoring data generated by a pharmaceutical chromatography/separation system, wherein said chromatography/separation system produces a drug product; b) maintaining the data over time to provide a historic record; c) analyzing the historic record to provide a quality assurance determination for said drug product; d) taking corrective action to obviate a failure against said quality assurance determination.
12 ) The method of claim 11 , wherein the quality assurance determination is based on a quality assurance protocol.
13 ) The method of claim 11 , wherein the historic record is maintained in a SQL database.
14 ) The method of claim 11 , wherein the chromatography/separation system comprises a specialty gas system.
15 ) The method of claim 11 , wherein the chromatography/separation system comprises a mixing tank.
16 ) The method of claim 11 , wherein the chromatography/separation system comprises a plurality of mixing tanks.
17 ) The method of claim 11 , wherein the chromatography/separation system comprises a bioreactor.
18 ) The method of claim 11 , wherein the chromatography/separation system comprises a vessel.
19 ) The method of claim 11 , wherein the chromatography/separation system comprises a filtration system.Join the waitlist — get patent alerts
Track US2016041551A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.